Rejection of B16 melanoma induced by expression of a transfected major histocompatibility complex class I gene.

AUTOR(ES)

Tanaka, K

RESUMO

Transfection of a functional major histocompatibility complex class I gene into certain tumor cells, induced by oncogenic viruses or chemical carcinogens, can effectively abrogate their tumorigenic activity. Since experimentally induced tumors possess strong tumor-specific transplantation antigens, expression of cell surface class I antigens may present the tumor cells to appropriate immune effector cells. Most spontaneously arising tumors do not possess tumor-specific transplantation antigens, and their tumorigenicity may not be affected by the expression of a transfected class I gene. We demonstrate that the poorly immunogenic B16-BL6 melanoma can be rendered nontumorigenic in syngeneic mice by the expression of the class I H-2K antigen but not the class II I-A antigen. Furthermore, the poorly tumorigenic, class I-expressing B16-BL6-transfected cells can effectively immunize syngeneic C57BL/6 mice against the highly tumorigenic, class I-deficient B16-BL6 parental cells. Our success in experimentally manipulating the tumorigenicity of a spontaneously derived neoplasm offers hope for a potential modality for the effective treatment of human cancer.

Documentos Relacionados

• Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens.
• Functional and inducible expression of a transfected murine class II major histocompatibility complex gene.
• Activation of class I major histocompatibility complex gene expression by hepatitis B virus.
• Expression in L cells of transfected class I genes from the mouse major histocompatibility complex.
• Pseudorabies virus-induced suppression of major histocompatibility complex class I antigen expression.